Beckman Coulter plans $4, high-volume COVID-19 antigen test

Beckman Coulter plans to launch a $4 coronavirus antigen test designed for mass screening, with the goal of shipping up to 25 million per month by March.The Access antigen assay is designed for high-throughput laboratory hardware and can deliver individual results in 30 minutes while processing up to 200 samples per hour. The company said it is currently submitting the test to the FDA for emergency review.
Read Full Article